American Physicians Capital reports completion of $10M authorization under 10b5-1 stock repurchase plan

NewsGuard 100/100 Score

American Physicians Capital, Inc. (NASDAQ:ACAP) today announced it has completed its October 2, 2009 $10 million authorization under its 10b5-1 stock repurchase plan. The Company has commenced its $20 million authorization under its 10b5-1 plan approved by its Board of Directors on December 3, 2009.

Year to date through February 16, 2010, the Company has repurchased 216,900 shares at an average price of $28.51 per share. Since the inception of our share repurchase program in 2001 through yesterday, the Company has repurchased 14.5 million shares at an average price of $19.66 per share. The Company has the following outstanding share repurchase authorizations:

Depending on market conditions, the Company may conduct additional discretionary repurchases in the open market or in privately negotiated transactions during its normal trading windows. Any discretionary repurchases will be made under the outstanding February 2008 authorization, which has $16.0 million remaining as of today.

In June 2009, the Company’s Board of Directors declared a four-for-three stock split of its common shares to shareholders. All share and per share numbers disclosed in this press release are split adjusted.

Source:

American Physicians Capital, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.